CURE-19

Curated by Signal

Provider of COVID-19 clinical trail study software for patients and researchers

Overview

Provider of COVID-19 clinical trail study software for patients and researchers. The company has developed a clinical trial at the home platform that allows patients to be a part of clinical studies provided by different researchers or organizations. The platform allows patients or participants to join different COVID-19 studies for researchers to analyze population trends, health analysis, and drug discovery needs.

Key facts

Founded: 2020
Headquarters: San Francisco, United States
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Intelligencia
Cloud and AI-led analytics platform for drug discovery and development
Health TechnologyNew York City, United States
Qtis
AI-based skin analysis tool for health providers
Health TechnologyCupertino, United States
Foundation Health
Provider of virtual health and telehealth platform for pharmacies and hospitals
Health TechnologySan Mateo, United States

About CURE-19

What does CURE-19 do?

Provider of COVID-19 clinical trail study software for patients and researchers.

Where is CURE-19 headquartered?

CURE-19 is headquartered in San Francisco, United States.

When was CURE-19 founded?

CURE-19 was founded in 2020.

Which sector is CURE-19 in?

CURE-19 operates in Health Technology.

Who are CURE-19's competitors?

Companies similar to CURE-19 include Intelligencia, Qtis, and Foundation Health.